Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Quantitative objective markers for upper and lower motor neuron dysfunction in ALS.

H Mitsumoto1, A M Ulug, S L Pullman

  • 1Eleanor and Lou Gehrig MDA/ALS Research Center, Columbia University, New York, NY 10032, USA. hm246@columbia.edu

Neurology
|April 25, 2007
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Longitudinal evaluation of diffusion tensor imaging and cognition in systemic lupus erythematosus.

Lupus·2018
Same author

Preoperative grading of supratentorial gliomas using high or standard b-value diffusion-weighted MR imaging at 3T.

Diagnostic and interventional imaging·2017
Same author

Functional Magnetic Resonance Imaging of Working Memory and Executive Dysfunction in Systemic Lupus Erythematosus and Antiphospholipid Antibody-Positive Patients.

Arthritis care & research·2016
Same author

A full-brain, bootstrapped analysis of diffusion tensor imaging robustly differentiates Parkinson disease from healthy controls.

Neuroinformatics·2014
Same author

Transcranial magnetic stimulation in ALS: utility of central motor conduction tests.

Neurology·2009
Same author

Accurate localization of brain activity in presurgical FMRI by structure adaptive smoothing.

IEEE transactions on medical imaging·2008
Same journal

Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD: A Multicenter Cohort Study.

Neurology·2026
Same journal

Cost-Effectiveness of Intracranial Aneurysm Screening: A Systematic Review.

Neurology·2026
Same journal

Rare Eating Epilepsy: Co-Occurrence of Focal Cortical Dysplasia and Gray Matter Heterotopia.

Neurology·2026
Same journal

Spatiotemporal Associations Between Cortical Microinfarcts and Cortical Superficial Siderosis in Cerebral Amyloid Angiopathy.

Neurology·2026
Same journal

Blood-Brain Barrier Disruption Before Interhospital Transfer for Thrombectomy and Clinical Outcome.

Neurology·2026
Same journal

At Death's Door: Cytosolic Dopamine in Patients With Parkinson Disease.

Neurology·2026
See all related articles
This summary is machine-generated.

Objective biomarkers like proton MR spectroscopic imaging and motor unit number estimation show promise in identifying upper and lower motor neuron involvement in Amyotrophic Lateral Sclerosis (ALS). These markers correlate with disease activity and offer insights into ALS pathobiology.

Area of Science:

  • Neurology
  • Neuroscience
  • Biomarker Discovery

Background:

  • Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disease affecting motor neurons.
  • Distinguishing between upper motor neuron (UMN) and lower motor neuron (LMN) involvement is crucial for understanding ALS progression and potential treatments.
  • Objective biomarkers are needed to accurately assess UMN and LMN involvement in ALS.

Purpose of the Study:

  • To evaluate the diagnostic and prognostic value of objective biomarkers for UMN and LMN involvement in ALS.
  • To compare these biomarkers with established clinical assessments in ALS patients and controls.

Main Methods:

  • A prospective study of 64 ALS patients and control subjects.
  • Utilized proton MR spectroscopic imaging ((1)H MRSI), diffusion tensor imaging, transcranial magnetic stimulation, and motor unit number estimation (MUNE).

Related Experiment Videos

  • Clinical measures and functional assessments were performed over 15 months.

    • Main Results:

    • Reduced N-acetyl-aspartate (NAA) in primary motor cortex (1H MRSI) was observed in ALS and UMN syndromes.
    • Prolonged central motor conduction time to the tibialis anterior indicated UMN involvement.
    • Lower MUNE in ALS and LMN syndromes demonstrated LMN involvement.
    • All biomarkers correlated with clinical measures, reflecting disease activity.

    Conclusions:

    • Proton MR spectroscopic imaging (NAA levels), central motor conduction time, and MUNE are significant objective biomarkers differentiating ALS and its subtypes from controls.
    • These biomarkers show potential for providing deeper insight into the underlying pathobiology of ALS.
    • Further research can explore their utility in monitoring disease progression and treatment response.